Ledger.Open graph →
SEC Form D · filed March 12, 2014

Corbus Pharmaceuticals Holdings, Inc

Offering
$30K
Sold
$20K
Exemption
Rule 506(b)
Industry
Investing
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

John Brancaccio · New York, NYExecDavid Hochman · New York, NYExec · DirectorStewart N. Cleveland · George Town, Grand Cayman, Cayman IslandsExec · DirectorJohn Brancaccio · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗